Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Mapping Molecular Discordance in the Brain
Omics Proteomics News and Research Mass Spectrometry Translational Science

Mapping Molecular Discordance in the Brain 

Single-cell proteomics reveals cell-type-specific regulation invisible to RNA-based methods 

03/03/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: Mapping Molecular Discordance in the Brain

Overview

A single-cell proteomics study reveals significant discordance between gene expression and protein abundance in the developing human brain. This research highlights the importance of protein-level analysis in understanding cellular identity and neurodevelopmental vulnerabilities.

Background

Understanding the molecular mechanisms underlying brain development is crucial for addressing neurodevelopmental disorders. Traditional RNA-based approaches may overlook critical post-transcriptional regulatory processes that influence protein expression. This study employs a novel mass spectrometry technique to provide a more accurate representation of protein dynamics in prenatal human brain tissue.

Data Highlights

Gestational WeekCell Types AnalyzedProteins Quantified
13Over 1,500Hundreds
15Over 1,500Hundreds
19Over 1,500Hundreds

Key Findings

  • Extensive discordance between RNA and protein levels across nearly all cell types.
  • Protein abundance is more cell-type-specific than mRNA levels.
  • Post-transcriptional regulation plays a central role in defining cellular identity during brain development.
  • High-risk genes for autism spectrum disorders showed high transcript levels but constrained protein abundance.
  • Protein co-expression analysis revealed conserved modules during the transition from intermediate progenitor cells to excitatory neurons.

Clinical Implications

The findings underscore the need for protein-first biomarkers in clinical settings, particularly for neurodevelopmental disorders. Understanding protein regulation during critical developmental windows may inform strategies for early intervention and treatment.

Conclusion

This study advances our understanding of brain development by highlighting the importance of protein-level analysis. Future research integrating proteomics with genetic data could further elucidate the mechanisms underlying neurodevelopmental disorders.

References

  1. The Analytical Scientist, 2026 -- A Molecular Atlas of the Alzheimer’s Brain
  2. Cedars-Sinai Pulse -- A New Brain ‘Traffic Map’
  3. BMC Psychiatry (Springer) -- Dynamic functional connectivity and coupling analysis of triple networks and white matter functional networks in first-episode schizophrenia patients: mechanisms revealed by follow-up studies
  4. Brain -- Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders
  5. New Clinical Practice Guideline for Blood-Based Biomarkers | AAIC
  6. New Clinical Practice Guideline for Blood-Based Biomarkers | AAIC
  7. Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study - ScienceDirect
  8. JOINT TRAUMA SYSTEM CLINICAL PRACTICE GUIDELINE

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.